Hassan Adwan

Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

N-[4-(Benzyloxy)-3-methoxybenzyl)]adamantane-1-amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer.

N-[4-(Benzyloxy)-3-methoxybenzyl)]adamantane-1-amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer.

Journal: Archiv der Pharmazie

Published: February 24, 2024

Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis.

Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis.

Journal: Journal of cancer research and clinical oncology

Published: July 02, 2020

Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes.

Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes.

Journal: Genes & cancer

Published: January 04, 2019

CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer.

CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: November 12, 2018

A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia.

A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia.

Journal: Frontiers in oncology

Published: July 23, 2018

The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis.

The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis.

Journal: Oncology letters

Published: April 06, 2017

Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma.

Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma.

Journal: Frontiers in oncology

Published: February 28, 2017

The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis.

The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 30, 2015

Riproximin modulates multiple signaling cascades leading to cytostatic and apoptotic effects in human breast cancer cells.

Riproximin modulates multiple signaling cascades leading to cytostatic and apoptotic effects in human breast cancer cells.

Journal: Journal of cancer research and clinical oncology

Published: May 13, 2015

Riproximin: A type II ribosome inactivating protein with anti-neoplastic potential induces IL24/MDA-7 and GADD genes in colorectal cancer cell lines.

Riproximin: A type II ribosome inactivating protein with anti-neoplastic potential induces IL24/MDA-7 and GADD genes in colorectal cancer cell lines.

Journal: International journal of oncology

Published: May 05, 2015

CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells.

CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells.

Journal: Medical oncology (Northwood, London, England)

Published: March 05, 2015

Riproximin's activity depends on gene expression and sensitizes PDAC cells to TRAIL.

Riproximin's activity depends on gene expression and sensitizes PDAC cells to TRAIL.

Journal: Cancer biology & therapy

Published: June 12, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026